background: Alterations in RNAs present in sperm have been identified using microarrays in teratozoospermic patients and in other types of infertile patients. However, so far, there have been no reports on using microarrays to determine the RNA content of sperm from asthenozoospermic patients.
Introduction
It is well known that the human sperm cell contains RNA although its functional significance remains to be established (Miller et al., 2005; Lalancette et al., 2009; Johnson et al., 2011; Krawetz et al., 2011) . Some RNAs in the mature sperm cell may be remnants from spermatogenesis with no function but its presence may still be potentially useful to evaluate the past events occurring during spermatogenesis and therefore to be used as markers to assess the fertility status (Miller et al., 2005; Lalancette et al., 2009) . Sperm RNAs could also have a role in the oocyte upon fertilization (Ostermeier et al., 2004; Krawetz, 2005; Carrell, 2008; Lalancette et al., 2008; Krawetz et al., 2011) . Using a microarray-based strategy, the mRNA fingerprint present in the human sperm cell was initially obtained from normal fertile men (Ostermeier et al., 2002) . Subsequently, also using microarrays, it has been demonstrated that a subset of sperm RNAs is present in an altered amount in infertile teratozoospermic patients (abnormal sperm morphology) (Platts et al., 2007) , and more recently in infertile patients (Garcia-Herrero et al., 2011) . Apart from these microarray-based studies, some spermatozoa RNAs have also been explored as potential clinical markers of infertility in abnormal sperm samples using real-time PCR (Lambard et al., 2004; Wang et al., 2004; Cedenho et al., 2006; Depa-Martynow et al., 2007; Guo et al., 2007; Jedrzejczak et al., 2007; Kempisty et al., 2007; Steger et al., 2008; Avendano et al., 2009) .
Impaired motility of the sperm cells is one of the major anomalies associated with male infertility. Different studies have reported a reduction of specific sperm motility-related transcripts in asthenozoospermic patients (low motility sperm). Specifically, a significant reduction in the abundance of TPX-1, testis-specific protein 1; LDHC, lactate deshydrogenase C transcript variant 1; PRM1, protamine 1; PRM2, protamine 2; HILS1, histone H1-like protein; TNP1, transition protein 1 and TNP2 transition protein 2 have been reported Jedrzejczak et al., 2007; Kempisty et al., 2007) . However, to our knowledge, the presence of RNAs in asthenozoospermic patients has not yet been studied using a microarray-based strategy. Therefore, we started the present project with the goal of characterizing the RNA abundance in asthenozoospermic patients when compared with controls and evaluating the relative quantity of protamine transcripts in our samples.
Materials and Methods

Study population and sample collection
Sperm samples were obtained after informed consent from 29 infertile patients (17 asthenozoospermic and 12 normozoospermic) and from 7 fertile controls from the Assisted Reproduction Unit of the Hospital Clinic of Barcelona (Supplementary data, Table S1 ). The infertile patients corresponded to couples unsuccessfully trying to achieve a pregnancy for at least one full year. The fertile controls corresponded to normozoospermic semen samples provided by semen donors of proven fertility (resulting in a pregnancy) within the last year. Semen samples were collected in specific sterile containers after at least 3 days of sexual abstinence and were allowed to liquefy. After liquefaction of the semen, sperm parameters were evaluated according to published recommendations (World Health Organization, 2010) using a computer-assisted semen analyser (Proiser, Valencia, Spain). Sperm morphology was evaluated using Kruger strict criteria (Kruger et al., 1987) and at least 100 cells were examined per slide. Infertile patients were divided into subgroups according to alterations of sperm motility. All 17 asthenozoopermic patients satisfied the World Health Organization (2010) criteria for asthenozoospermia defined as ,32% progressive motility (grades a + b). All seven fertile controls were classified as normozoospermic according to the World Health Organization (2010) criteria. Significant differences in the sperm motility were present between the asthenozoospermic patients and the normozoospermic fertile controls (Table III) . Protamine ratios were determined as previously described (Jodar et al., 2011) .
Isolation of RNA from sperm samples
To rule out the possibility of any somatic cells contamination, we performed a 50% Percoll Gradient sperm selection (800 g, 20 min) followed by two phosphate-buffered saline washes. After this initial purification, the samples were treated with somatic cell lysis buffer (0.1% SDS, 0.5% Triton X-100). Optical phase contrast microscopic examination (20×) was then used to verify the elimination of the somatic cells . The RNA was then extracted from 15-30 × 10 6 sperm cells and purified using the Qiagen miRNeasy Kit according to the manufacturer's recommendations. The RNA samples were subjected to different quality controls. In the first one, in order to determine the purity and concentration of the RNA, the samples were checked spectrophotometrically at 260 and 280 nm. In the second one, in order to determine the RNA integrity, the samples were analyzed using a Bioanalyzer. The majority of the RNAs ranged between 0.2 and 2 kb, which is correct for sperm RNA. In addition spermatozoa are rRNA depleted. Thus, rRNA cannot be used as a marker of RNA quality ( Fig. 1A and B). A third control was performed to verify the absence of RNA from leukocytes in RNA samples by performing a RT -PCR for the leukocytespecific marker CD45 ( Fig. 1C ; Table II ) (Lambard et al., 2004) . Finally, in order to asses that the RNA samples were not degraded and did not have any genomic or mitochondrial DNA contamination, we performed a RT-PCR for the PRM2 gene with exon spanning primers ( Fig. 1D ; Table II ) and for the mitochondrial region DLOOP, which is not transcribed ( Fig. 1E ; Table II ).
Microarray hybridization and quantification
We selected four asthenozoospermic patients and four normozoospermic fertile controls to be analysed by microarray hybridization (Supplementary data, Table S1 ). The total RNA (50 ng) was converted to cDNA using one-cycle cDNA Synthesis Kit of Affymetrix Santa Clara, CA, USA. After transcription to cRNA, the transcripts underwent biotin labelling using the IVT Labelling Kit protocol of Affymetrix. Biotin-labelled cRNA was fragmented and hybridized to oligonucleotide Affymetrix Human Genome 133 Plus 2 arrays, representing about 38 500 well-characterized genes. Washes and scanning of the arrays were performed according to the manufacturer's instructions. Expression measures were normalized and summarized using the Robust Multi-array Average methodology (Irizarry et al., 2003) . The results corresponding to the microarray data set were submitted to the GEO (NCBI) repository (accession number GSE34514). Subsequent statistical differential gene expression analysis was performed by the non-parametric approach Rank Prod (Breitling et al., 2004) in the TM4 Software Suite (Saeed et al., 2006) . Rank Prod detects features that are consistently highly ranked in a number of replicate experiments, and is a method that has shown robustness to outliers, being suitable for noisy data. Those probe-sets that present changes between the two groups with q-value lower than 0.05 were considered significant.
Real-time PCR
Some of the detected transcripts were selected to further validate their differential abundance using real-time PCR. We also decided to include in the present work the study of the protamine PRM1 and PRM2 transcripts because an abnormal PRM1/PRM2 protein ratio contributes to abnormal chromatin condensation (Oliva, 2006; Jodar et al., 2011) and increased DNA strand breaks phenomena which are correlated with impaired motility of the sperm cell (Miyagawa et al., 2005) . Using 50 or 100 ng total RNA template, cDNA was prepared using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Real-time RT -PCR was performed using Lightcycler FastStart DNA Master Plus SYBR green I and a Lightcycler 2.0 instrument (Roche Applied Science, Indianapolis, IN, USA) in a 20 ml total reaction volume, containing 2 ml cDNA and 0.5 mM of each sense and antisense primer. The primers were designed using Primer 3 software. The primer sequences, annealing temperature and the expected lengths of the resulting PCR products are summarized in Table II . Melting curve analysis was performed after each run to verify specific amplifications. All PCR products exhibited a single peak in melting curves and were identified as single bands of the appropriate size on gel red stained-agarose gel electrophoresis. In addition, the specificity of the amplifications was confirmed by sequencing of PCR products purified using Exosap. The samples were quantified using the DDC t method (Livak and Schmittgen, 2001) . The expression values obtained were normalized against the housekeeping gene b-actin (ACTB) to account for differing amounts of starting material. All determinations were performed in duplicate for two different initial quantities of total RNA (50 -100 ng).
Statistical analysis
Data are presented as mean + SEM (Table III) . Statistical analyses were performed using SPSS software, version 16.0 (SPSS Corp., Chicago, IL, USA), and statistical tests were deemed significant at P , 0.05. A non-parametric Mann-Whitney test was used to detect differences in the average of relative quantification of the different transcripts chosen between the two different populations studied (Table III) . The potential correlations between the seminal parameters and the relative quantification of the different transcripts were evaluated using a non-parametric Spearman test (Fig. 2C and D) .
Results
Genes detected at a differential abundance in asthenozoospermic patients using a microarray-based strategy
The genes detected with a different abundance in asthenozoospermic patients compared with fertile donors are shown in Table I . We found 17 transcripts significantly decreased and two increased in asthenozoospermic patients. Sixteen of these differential transcripts are among the 10% most highly expressed sequences reported in human sperm. Also, it is interesting to note that 10 of 19 transcripts with a different abundance correspond to uncharacterized or predicted proteins. Ontological and pathway mapping of the differentially abundant transcripts detected that the spermatid development and the ubiquinone biosynthesis pathways are altered in sperm from asthenozoospemic patients when compared with fertile donors (not shown). Of the genes detected at an increased or at a decreased abundance, we selected five potentially related to sperm motility or spermatogenesis (based on published data) to validate their differential expression in a higher number of samples using real-time PCR. The chosen transcripts were ANXA2, BRD2, mtND2, mtND3 and OAZ3.
Validation of the cDNA microarray results using real-time PCR asthenozoospermic patients (n ¼ 16) and fertile normozoospermic controls (n ¼ 6) (P , 0.05; Table III) . No significant differences were found for any of the two selected mitochondrial transcripts (mtND2 and mtND3) (Table III) . Subsequently, we selected the two most differential transcripts (ANXA2 and BRD2) to further study their relative abundance in a new group of patients (infertile normozoospermic patients; n ¼ 12) with a good motility (progressive motility a + b .40%; World Health Organization, 2010). We observed a higher content of the two transcripts studied in the normozoospermic patients when compared with asthenozoospermic patients, but the differences were not significant ( Fig. 2A and B) . However, we found a significant positive correlation between the sperm progressive motility (a + b) and the relative mRNA levels of the ANXA2 and BRD2 transcripts (P , 0.05; Fig. 2C and D) .
Protamine mRNA expression
The amounts of protamine transcripts as measured in the microarrays were lower in asthenozoospermic patients when compared with fertile donors, but the differences were not statistically significant (for the PRM1 transcript the ratio was 0.876 and the q-value 0.384 and for the PRM2 transcript the ratio was 0.794 and the q-value 0.222). However, based on the study of Kempisty et al. (2007) , where they found a higher content of PRM1 and PRM2 transcripts in spermatozoa of normozoospermic men versus asthenozoospermic men, we also decided to evaluate the relative quantity of the protamines transcripts in a larger group of samples using real-time PCR. Consistently with the previous results, we also found significant differences in the abundance of the PRM1 and PRM2 transcripts between asthenozoospermic patients and fertile controls (Table III) . In addition, we also observed differences between normozoospermic patients and fertile controls that narrowly failed to reach statistical significance for PRM2 (PRM1, P ¼ 0.010 and PRM2, P ¼ 0.067) but no significant differences were found between asthenozoospermic and normozoospermic patients. These results may indicate that the differences in the abundance of the protamines are more correlated with the fertility status than with the motility parameters. We also explored whether there were any correlations between protamine transcripts and the P1/P2 ratios as previously found by other authors (Aoki et al., 2006 ), but we did not detect any significant difference. This may be because the number of patients having an abnormal P1/P2 ratio (,0.8 and .1.2; Jodar et al., 2011) among the asthenozoospermic patients is very small (Supplementary data, Table S1 ).
Discussion
In this work, we have used a microarray-based strategy to identify differentially abundant transcripts in asthenozoospermic infertile patients when compared with fertile controls. Subsequently, we have used realtime PCR to validate the detected over or under represented transcripts in a larger number of samples. Ontological and pathway mapping of the differentially abundant transcripts detected in the microarray assay revealed that the spermatid development and the ubiquinone biosynthesis pathways were both altered in asthenozoospermic patients when compared with fertile controls. These results are similar to those obtained in a recent study that compared infertile males and fertile controls using a microarray strategy and where the ontological analysis revealed that infertile patients had a differential abundance of genes implicated in the spermatid development and in energy production (Garcia-Herrero et al., 2010) . It is interesting to note that about half of the differential transcripts detected correspond to uncharacterized or predicted proteins (Table I ). It will be interesting to characterize these proteins in subsequent studies and to identify their role in spermatogenesis or in sperm motility.
To validate the results from microarray analysis, the relative abundance of five transcripts that were decreased in the asthenozoospermic patients (ANXA2, BRD2, mtND2, mtND3 and OAZ3) was measured in a higher number of subjects using real-time PCR. ANXA2 is a transcript that encodes a calcium-binding protein which may play a key role in the initiation and regulation of sperm motility. BRD2 encodes a transcriptional regulator that belongs to the bromodomains and extra terminal domain family of proteins that probably plays a role in spermatogenesis. The mitochondrial transcripts (mtND2 and mtND3) encode proteins that are part of the mitochondrial respiratory chain and there is some evidence to suggest that the mitochondria may play a key role in the energy maintenance of spermatozoan motility (Amaral et al., 2007) . Finally, we also included the OAZ3 transcript, because OAZ3 knock-out homozygous male mice are infertile and their sperm cells have an altered motility (Tokuhiro et al., 2009) . The results confirmed a significant lower abundance in asthenozoospermic patients of three of the five transcripts selected (ANXA2, BRD2 and OAZ3) (Table III) .
We subsequently selected the transcripts with the largest differences in abundance (ANXA2 and BRD2) to study their abundance in an independent group of infertile men with good sperm motility (normozoospermic). In this group, we also observed differences in the expression of these two genes when compared with asthenozoospermic patients (Fig. 2) . The results in the normozoospermic patients indicated an intermediate situation between the asthenozoospermic patients and the fertile controls, indicating some degree of dysfunction of these genes also in this group of patients (Fig. 2) . In addition, a positive correlation with the progressive velocity was observed (Fig. 2) 
These results suggest that lower abundance of Annexin A2 and the Bromodomain 2 transcripts could be associated with asthenozoospermia and may be useful as a marker to assess the fertility status (Table III) . Annexin A2 is a calcium-binding protein that is found in the acrosome and flagellum of the sperm cell and could be implicated in different events that are known to be calcium dependent, such as flagellar motility, acrosome reaction and fertilization (Feinberg et al., 1991) . Our results suggest that lower Annexin A2 mRNA levels are associated with poor flagella motility. Different studies shown that the bromodomain 2 protein may be involved in chromatin remodelling during spermatogenesis (Shang et al., 2004; Umehara et al., 2010) and the disruption of BRD2 expression leads to embryonic lethality (Gyuris et al., 2009) . It is interesting to note that this gene is present in a region that may be linked to non-obstructive azoospermia, although so far no mutations have been detected (Matsuzaka et al., 2002) . Our results are also consistent with the finding that the BRD2 transcript has been found at higher abundance in fertile controls when compared with infertile patients (Garcia-Herrero et al., 2010) . Epigenetic modifications of the chromatin structure, such as histone acetylation and methylation, are known to have important consequences in the regulation of spermatogenesis, and therefore the lower abundance of BRD2 transcript could be related with an altered spermatogenesis and infertility. It will be interesting to further study the potential clinical utility of these transcripts. In this work, we also measured the abundance of the protamine mRNAs because an abnormal P1/P2 ratio is related to an abnormal chromatin condensation and increased DNA strand breaks, which may initiate the apoptotic signalling pathway inducing the inactivation of mitochondria and the immotility of spermatozoa (Miyagawa et al., 2005; Castillo et al., 2011) . Our results are consistent with different studies reporting a decreased abundance of the protamine genes in infertile asthenozoospermic patients (Lambard et al., 2004; Kempisty et al., 2007) . Consistently with these studies, our results also indicate that there are a higher levels of PRM1 and PRM2 transcripts in the fertile controls when compared with asthenozoospermic and normozoospermic infertile patients.
In the present work, we have detected several RNAs present in altered amounts in asthenozoospermic patients through microarray analysis followed by validation of the results using real-time PCR. These results open up the possibility to gain further insight into the pathogenic mechanisms involved in asthenozoospermia and to consider the potential use of the detected RNAs as infertility biomarkers. It will also be interesting to determine if the present findings of altered RNAs may also be related to ultrastructural defects (Courtade et al., 1998) or to alterations in the corresponding proteins as derived from ongoing proteomic studies (Martinez-Heredia et al., 2008; Oliva et al., 2009; Siva et al., 2010; de Mateo et al., 2011) .
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